|
|
|
Chemical Database |
| |
Elsevier Acquires the
Beilstein Database, World's Leading Archive of Chemical Data
Other Topics:
Medical Informatics Disease
Management,
Telemedicine Initiative
PRNewswire-FirstCall
March 26, 2007
10 Million Unique Reactions to be Further Integrated into
Researcher's Workflow
Amstaerdam, Netherlands -- Elsevier, the leading global
publisher of scientific, technical and medical information,
today announced the acquisition through its subsidiary MDL
Information Systems GmbH, of the Beilstein Database, the world's
largest compilation of chemical facts and the premier database
in the field of organic chemistry.
Elsevier has been exclusively involved in both the production
and marketing of the Beilstein Database under a partnership
agreement since 1998. Since then, Elsevier has added or updated
close to 5 million compounds to the database and has helped to
build a strong and established customer base in both the
corporate pharmaceutical and academic sectors. As a result of
the agreement announced today, Elsevier will assume ownership
and acquire the rights to the Beilstein Database. |
| |
|
|
| |
The
Beilstein Database covers organic chemistry from 1771 to date.
It contains over 9.8 million compounds, 10 million reactions
(making it the world's largest reaction database) and 320
million experimental data on chemical properties. It also
contains over 900,000 original author abstracts from
1980-present, as well as pharmacological and ecotoxicological
data describing the bioactivity of organic chemicals.
"This will open a new chapter for the Beilstein-Institut," noted
Dr. Martin G. Hicks, Director of the Beilstein-Institut, "We
look forward to further developing diverse activities including
innovative software and journals such as the Beilstein Journal
of Organic Chemistry."
"Acquiring the Beilstein Database, with its great legacy and
contribution to science, is a natural opportunity and fit for
Elsevier," said Herman van Campenhout, Chief Executive Officer,
Science and Technology, Elsevier. "As one of the world's most
significant scientific resources, it is especially valuable for
our pharmaceutical industry customers working in the area of
drug discovery."
Elsevier has already pioneered closer integration between
chemical structure data and text information. For example via
the Crossfire and DiscoveryGate interfaces, customers already
enjoy seamless linking between Scopus, Elsevier's highly
acclaimed abstract & indexing database, and the chemical
reactions and compounds in the Beilstein Database.
Michiel Kolman, Managing Director, Elsevier MDL in Frankfurt,
where the Beilstein database is produced, stated, "We are very
excited about the opportunities to bring even further
efficiencies to the researcher's workflow by applying innovative
approaches to integration between different data resources."
About Beilstein-Institut
The Beilstein-Institut is a non-profit foundation and pursues
its mission for the advancement of chemical sciences
particularly through information and communication. The
Beilstein-Institut is owner of the Beilstein Handbook of Organic
Chemistry, the MedPhyt medicinal plants database, and software,
such as, the Beilstein Chemical Toolkit (BCT) and Structure
Editor, and the Autonom chemical nomenclature program. The
Beilstein Journal of Organic Chemistry (BJOC); a high quality,
fully refereed journal, is published as a free access online
journal www.beilstein-journals.org/bjoc.
The Beilstein-Institut is planning to extend its activities in
the above areas by increasing the functionality, content and
number of products; where possible making them freely available
to the scientific community. Free access to the proceedings of
the Beilstein-Institut hosted symposia is available on
www.beilstein-institut.de
About MDL Information Systems GmbH and Elsevier MDL
MDL Information Systems GmbH and Elsevier MDL provide
informatics, database and workflow solutions that accelerate
successful life sciences R&D by improving the speed and quality
of scientists' decision making. Researchers around the world
depend on Elsevier MDL and MDL Information Systems GmbH for
innovative and reliable discovery informatics software solutions
and services augmented by 400 Elsevier chemistry and life
sciences journals and related products. For more information,
visit www.mdl.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. Working in
partnership with the global science and health communities,
Elsevier's 7,000 employees in over 70 offices worldwide publish
more than 2,000 journals and 1,900 new books per year, in
addition to offering a suite of innovative electronic products,
such as ScienceDirect (http://www.sciencedirect.com/), MD
Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business
headquartered in Amsterdam, The Netherlands and has offices
worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/),
a world-leading publisher and information provider. Operating in
the science and medical, legal, education and
business-to-business sectors, Reed Elsevier provides high-
quality and flexible information solutions to users, with
increasing emphasis on the Internet as a means of delivery. Reed
Elsevier's ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).
Source: Elsevier B V |
| |
|
|
| |
|
|
